Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Antengene Corporation Raises $120 Million in Series B Financing 2019-01-02 08:45
Innovent Announces First Patient Dosed in a Phase III Clinical Trial of Anti-PD-1 Antibody Tyvyt® (Sintilimab injection) as First-line Treatment for Patients with Advanced Esophageal Cancer 2019-01-02 08:00
Luye Pharma Announces Innovative Drug - Risperidone Extended Release Microspheres for Injection has Reached Final Stage of NDA Process 2018-12-31 08:00
InventisBio and Betta Pharma to Co-Develop Novel Drug for Non-Small Cell Lung Cancer 2018-12-29 03:33
Bridge Biotherapeutics Announces a Successful Activation of U.S. Clinical Trial Sites for BBT-401 Phase 2 Study 2018-12-28 07:00
China's NMPA Approves Innovent's Anti-PD-1 Antibody Tyvyt® (Sintilimab injection) for Hodgkin's Lymphoma 2018-12-27 16:45
Focusing on CRO & CMO Industry Upgrading, ICSE China 2019 Helps Enterprises Seize New Industry Opportunities 2018-12-25 15:00
I-Mab Receives U.S. FDA IND Approval for Proprietary Anti-GM-CSF Monoclonal Antibody TJM2 2018-12-24 11:45
Helsinn Group Grants Exclusive Licensing Rights to Menarini for Pracinostat 2018-12-21 21:46
CStone Pharmaceuticals announces initiation of CS1001 Phase I Study in U.S., patient enrollment under way 2018-12-21 17:50
Mundipharma Applies to Market Remimazolam for General Anesthesia in Japan 2018-12-21 15:14
Gan & Lee and a Leading Pharmaceutical Company Enters into Global Collaboration to Commercialize Insulin Analog 2018-12-19 19:22
iSTAR Medical's MINIject maintains exceptional results in first-in-human trial one year post-surgery (STAR-I) 2018-12-19 16:00
Bridge Biotherapeutics Signs US$40M License Agreement with Daewoong Pharmaceutical for Co-development of UC Drug Candidate 2018-12-19 08:00
Ajinomoto and XL-protein Forge Strategic Alliance to Develop PASylated Therapeutics Applying the Corynex® Platform 2018-12-18 23:00
Artificial Intelligence Is Propelling the Pharmaceutical Industry by Enabling Smart Drug Discovery Solutions 2018-12-17 21:50
NeuClone Announces its Sixth Biosimilar Candidate Perjeta(R) (Pertuzumab) for use in Combination Therapy with Herceptin(R) (Trastuzumab) 2018-12-17 21:30
I-Mab and CSPC Pharma Announce Strategic Partnership for Long-acting GLP-1 Fc Program 2018-12-17 19:10
PharmaEssentia and AOP Orphan Receive Positive CHMP Opinion For Besremi(™) (Ropeginterferon alfa-2b) For Treatment Of Polycythemia Vera (PV) In EU 2018-12-17 16:00
Innovate and Win the Future through Intelligence, P-MEC China 2019 to "Set Sail" Intelligently 2018-12-17 15:00
1 328 329 330 331 332 401